$38.31
-1.28 (-3.23%)
At Close: Nov 17, 2025
Viking Therapeutics Earnings Calls
Oct 01, 2025
-$0.81 (-14.16%)
| Release date | Oct 22, 2025 |
| EPS estimate | -$0.710 |
| EPS actual | -$0.81 |
| EPS Surprise | -14.16% |
| Revenue estimate | - |
| Revenue actual | - |
Jul 01, 2025
-$0.580 (-29.90%)
| Release date | Jul 23, 2025 |
| EPS estimate | -$0.446 |
| EPS actual | -$0.580 |
| EPS Surprise | -29.90% |
| Revenue estimate | - |
| Revenue actual | - |
Mar 31, 2025
-$0.407 (-24.13%)
| Release date | Apr 23, 2025 |
| EPS estimate | -$0.328 |
| EPS actual | -$0.407 |
| EPS Surprise | -24.13% |
| Revenue estimate | - |
| Revenue actual | - |
Dec 30, 2024
-$0.320 (-16.01%)
| Release date | Feb 05, 2025 |
| EPS estimate | -$0.276 |
| EPS actual | -$0.320 |
| EPS Surprise | -16.01% |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for Viking Therapeutics
Below you can see how 0VQA.L performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Dec 30, 2024
Missed
| Release date | Feb 05, 2025 |
| Price on release | $33.24 |
| EPS estimate | -$0.276 |
| EPS actual | -$0.320 |
| EPS surprise | -16.01% |
| Date | Price |
|---|---|
| Jan 30, 2025 | $33.87 |
| Jan 31, 2025 | $33.97 |
| Feb 03, 2025 | $31.45 |
| Feb 04, 2025 | $32.74 |
| Feb 05, 2025 | $33.24 |
| Feb 06, 2025 | $31.11 |
| Feb 07, 2025 | $32.69 |
| Feb 10, 2025 | $30.30 |
| Feb 11, 2025 | $29.18 |
| 4 days before | -1.85% |
| 4 days after | -12.23% |
| On release day | -6.43% |
| Change in period | -13.86% |
Mar 31, 2025
Missed
| Release date | Apr 23, 2025 |
| Price on release | $26.19 |
| EPS estimate | -$0.328 |
| EPS actual | -$0.407 |
| EPS surprise | -24.13% |
| Date | Price |
|---|---|
| Apr 15, 2025 | $22.74 |
| Apr 16, 2025 | $23.48 |
| Apr 17, 2025 | $23.67 |
| Apr 22, 2025 | $24.79 |
| Apr 23, 2025 | $26.19 |
| Apr 24, 2025 | $25.38 |
| Apr 25, 2025 | $25.10 |
| Apr 28, 2025 | $24.51 |
| Apr 29, 2025 | $28.14 |
| 4 days before | 15.16% |
| 4 days after | 7.46% |
| On release day | -3.06% |
| Change in period | 23.75% |
Jul 01, 2025
Missed
| Release date | Jul 23, 2025 |
| Price on release | $33.47 |
| EPS estimate | -$0.446 |
| EPS actual | -$0.580 |
| EPS surprise | -29.90% |
| Date | Price |
|---|---|
| Jul 17, 2025 | $32.29 |
| Jul 18, 2025 | $32.06 |
| Jul 21, 2025 | $32.33 |
| Jul 22, 2025 | $31.95 |
| Jul 23, 2025 | $33.47 |
| Jul 24, 2025 | $33.76 |
| Jul 25, 2025 | $34.23 |
| Jul 28, 2025 | $33.95 |
| Jul 29, 2025 | $33.17 |
| 4 days before | 3.65% |
| 4 days after | -0.89% |
| On release day | 0.86% |
| Change in period | 2.73% |
Oct 01, 2025
Missed
| Release date | Oct 22, 2025 |
| Price on release | $31.11 |
| EPS estimate | -$0.710 |
| EPS actual | -$0.81 |
| EPS surprise | -14.16% |
| Date | Price |
|---|---|
| Oct 16, 2025 | $35.13 |
| Oct 17, 2025 | $33.35 |
| Oct 20, 2025 | $34.01 |
| Oct 21, 2025 | $33.00 |
| Oct 22, 2025 | $31.11 |
| Oct 23, 2025 | $34.32 |
| Oct 24, 2025 | $34.61 |
| Oct 27, 2025 | $35.34 |
| Oct 28, 2025 | $35.24 |
| 4 days before | -11.44% |
| 4 days after | 13.29% |
| On release day | 10.33% |
| Change in period | 0.329% |
Viking Therapeutics Earnings History
Earnings Calendar
FAQ
When is the earnings report for 0VQA.L?
Viking Therapeutics, Inc. (0VQA.L) has scheduled its earnings report for Feb 03, 2026 before the markets open.
What is the 0VQA.L price-to-earnings (P/E) ratio?
0VQA.L P/E ratio as of Nov 17, 2025 (TTM) is -18.63.
What is the 0VQA.L EPS forecast?
The forecasted EPS (Earnings Per Share) for Viking Therapeutics, Inc. (0VQA.L) for the first fiscal quarter 2025 is $.
What are Viking Therapeutics, Inc.'s retained earnings?
On its balance sheet, Viking Therapeutics, Inc. reported retained earnings of $0 for the latest quarter ending Oct 01, 2025.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Sign In
Buy 0VQA